16 Jun, 09:24 - Indian

Nifty IT 38646.25 (0.46)

Nifty Midcap 100 58348.8 (0.21)

Nifty Bank 55528.3 (0.00)

Nifty 50 24788.95 (0.28)

Nifty Pharma 21970.45 (-0.07)

Nifty Next 50 67071.25 (0.14)

SENSEX 81398.08 (0.34)

Nifty Smallcap 100 18440.7 (0.36)

16 Jun, 09:24 - Global

NIKKEI 225 38227.96 (1.04)

HANG SENG 23864.21 (-0.12)

S&P 5999.5 (0.14)


Corporate News

You are Here : Home > News > Corporate News >

(04 Jun 2025, 09:06)

Gland Pharma receives USFDA approval for Angiotensin II Acetate Injection 2.5 mg/mL


Gland Pharma has received approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application for Angiotensin II Acetate Injection 2.5 mg/mL.

The Product is bioequivalent and therapeutically equivalent to the reference listed drug (RLD), GIAPREZA ® of La Jolla Pharma LLC.

This Product is indicated for increasing the blood pressure in adults with septic or other distributive shock.

Gland Pharma is the exclusive First-to-File and is eligible for 180 days of generic drug exclusivity.

According to IQVIA, the product had US sales of approximately USD 58 million for the twelve months ending March 2025.


More News
More Company News View Company Information

Capital Market Publishers India Pvt. Ltd

401, Swastik Chambers, Sion Trombay Road, Chembur, Mumbai - 400 071, India.

Formed in 1986, Capital Market Publishers India Pvt Ltd pioneered corporate databases and stock market magazine in India. Today Capitaline corporate database cover more than 35,000 listed and unlisted Indian companies. Latest technologies and standards are constantly being adopted to keep the database user-friendly, comprehensive and up-to-date.

Over the years the scope of the databases has enlarged to cover economy, sectors, mutual funds, commodities and news. Many innovative online and offline applications of these databases have been developed to meet various common as well as customized requirements.

While all the leading institutional investors use Capitaline databases, Capital Market magazine gives access to the databases to individual investors through Corporate Scoreboard. Besides stock market and company-related articles, the magazine’s independent and insightful coverage includes mutual funds, taxation, commodities and personal finance.

Copyright @ Capital Market Publishers India Pvt.Ltd

Designed, Developed and maintained by CMOTS Infotech (ISO 9001:2015 Certified)

Site best viewed in Internet Explorer Edge ,   Google Chrome 115.0.5790.111 + ,   Mozilla Firefox 115.0.3 + ,   Opera 30.0+, Safari 16.4.1 +